This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
National Health Investors (NHI) Misses Q2 FFO Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of -0.73% and 1.42%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
National Health Investors (NHI) Q1 FFO Meet Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 0.00% and 2.68%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
National Health Investors (NHI) Meets Q3 FFO Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 0.00% and 0.93%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Prudential Financial (PRU) Q3 Earnings: A Beat in Store?
by Zacks Equity Research
Probable growth across businesses along with a possible revenue rise might aid Prudential Financial (PRU) in Q3.
Assurant, Inc. (AIZ) Q3 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Robust revenues, expected solid segmental performance at Global Lifestyle and Global Housing and a lower tax rate might aid Assurant's (AIZ) Q3 results. But rising expenses might be a downside.
Can Higher Premiums Drive CNA Financial's (CNA) Q3 Earnings?
by Zacks Equity Research
Improved premiums and better investment results might aid CNA Financial (CNA) in Q3. However, rising expenses and a probable catastrophe loss are a bane.
Are You Looking for a High-Growth Dividend Stock? National Health Investors (NHI) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does National Health Investors (NHI) have what it takes? Let's find out.
Why National Health Investors (NHI) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does National Health Investors (NHI) have what it takes? Let's find out.
National Health Investors (NHI) Q2 Earnings Meet Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered earnings and revenue surprises of 0.00% and -1.14%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
REITs to Watch for Q2 Earnings on Aug 7: SNH, NHI, RHP & HST
by Zacks Equity Research
While rising interest rates remains a concern for REITs, healthy consumer sentiment will have partly muted its impact in Q2. Let's see what's in store for SNH, NHI, RHP & HST.
Will Solid Portfolio Aid Host Hotels (HST) in Q2 Earnings?
by Zacks Equity Research
Host Hotels & Resorts' (HST) Q2 performance is expected to highlight benefits from its robust portfolio of upscale hotels across potential markets, solid group business and productivity gains.
CBRE Group (CBRE) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
CBRE Group's (CBRE) Q2 results likely to reflect strength across its global regions and growth in global occupier outsourcing business.
Is National Health Investors (NHI) a Good Pick for Income Investors?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does National Health Investors (NHI) have what it takes? Let's find out.
SL Green Realty (SLG) to Sell 600 Lexington Avenue for $305M
by Zacks Equity Research
SL Green Realty (SLG) agrees to sells 600 Lexington Avenue for $305 million as part of its strategy to shed non-core assets and acquire high-occupancy and rent-generating properties.
SL Green (SLG) Signs Deal to Sell 43% Stake in Office Tower
by Zacks Equity Research
SL Green Realty (SLG) will shed 43% stake of its fully-owned 1515 Broadway to Allianz Real Estate. The company will realize $416 million in cash proceeds when the transaction closes in 2018.
Top Ranked Income Stocks to Buy for November 15th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, November 15th:
Outfront Activates Signage Screen at Yonge-Dundas Square
by Zacks Equity Research
In an effort to revamp the public square, Outfront Media (OUT) installs digital screens at the Yonge-Dundas Square.
Top Ranked Income Stocks to Buy for November 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, November 10th:
Aging Americans to Aid Healthcare REITs: 3 Stocks to Buy Now
by Zacks Equity Research
Favorable demography amid the aging baby-boomer generation and greater longevity encourages healthcare REITs to tap opportunities and become resilient.
Top Ranked Income Stocks to Buy for August 29th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, August 29th:
5 Reasons to Add Rayonier (RYN) Stock to Your Portfolio Now
by Zacks Equity Research
Rayonier's (RYN) efforts to fortify its portfolio through strategic acquisitions are likely to drive growth.
Education Realty Receives Approval for College View Project
by Zacks Equity Research
Education Realty's (EDR) predevelopment agreement pertaining to College View university housing development project has been sanctioned by the State Institutions of Higher Learning.
REIT Q1 Earnings Coming Up on May 9: REG, CLNS, WPC, NHI
by Zacks Equity Research
Some REITs which are expected to report their quarterly figures on May 9 include Regency Centers Corporation (REG), Colony NorthStar, Inc. (CLNS), W. P. Carey Inc. (WPC) and National Health Investors Inc. (NHI).
National Health (NHI) Sells Shares Worth $80M on ATM Program
by Zacks Equity Research
National Health Investors Inc. (NHI) announced that during first-quarter 2017 ended Mar 31, it sold 1,123,184 common shares on its At-The-Market (ATM) equity program.
National Health Investors Buys 5 Memory Care Communities
by Zacks Equity Research
National Health Investors Inc. (NHI) announced the purchasing of five memory care facilities in Texas and Illinois for $61.8 million.